12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·03/31/2026 12:05:43
Listen to the news
Gainers
Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% to $40.81 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion.
Virax Biolabs Group (NASDAQ:VRAX) shares rose 62.43% to $0.26. The market value of their outstanding shares is at $1.2 million.
Centessa Pharmaceuticals (NASDAQ:CNTA) stock rose 47.49% to $40.68. The market value of their outstanding shares is at $4.0 billion.
Insight Molecular (NASDAQ:IMDX) stock rose 34.9% to $3.44. The company's market cap stands at $82.0 million. The company's, Q4 earnings came out 3 days ago.
IM Cannabis (NASDAQ:IMCC) stock increased by 30.19% to $0.53. The market value of their outstanding shares is at $2.4 million.
Lantern Pharma (NASDAQ:LTRN) stock rose 19.83% to $1.48. The company's market cap stands at $13.8 million. The company's, Q4 earnings came out yesterday.
Losers
PepGen (NASDAQ:PEPG) shares fell 48.7% to $2.17 during Tuesday's pre-market session. The company's market cap stands at $290.8 million.
Iterum Therapeutics (NASDAQ:ITRM) stock declined by 32.53% to $0.05. The company's market cap stands at $3.7 million.
Phreesia (NYSE:PHR) stock fell 24.19% to $8.65. The company's market cap stands at $687.8 million. As per the news, the Q4 earnings report came out yesterday.
Sangamo Therapeutics (NASDAQ:SGMO) stock fell 16.73% to $0.26. The market value of their outstanding shares is at $114.2 million. As per the news, the Q4 earnings report came out yesterday.
BioLife Solutions (NASDAQ:BLFS) stock fell 15.87% to $15.8. The company's market cap stands at $899.6 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.